BCL2 and malignant colon neoplasm: Furthermore, bcl-2/bcl-xL bispecific oligonucleotides significantly reduced Bcl-xL expression that leads to increased apoptosis and delayed tumour growth in a xenotransplantation model for colon cancer (Gautschi et al, 2001).